Comparison of the inhibitory activities of salvianolic acid B and Ginkgo biloba extract EGb 761 on neurotoxicity of β-amyloid peptide

Yaoxue Xuebao

Volumn 41, Issue 8, 2006, Pages 706-711

  Liu, Chang Suo ^a   Hu, Jin Feng ^a   Chen, Nai Hong ^a   Zhang, Jun Tian ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

amyloid peptide; Alzheimer's disease; Ginkgo biloda extract EGb 761; PC12 cell; Salvianolic acid B

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); BENZOFURAN DERIVATIVE; GINKGO BILOBA EXTRACT 761; HERBACEOUS AGENT; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; SALVIANOLIC ACID B;

ANIMAL; APOPTOSIS; ARTICLE; CELL STRAIN; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GINKGO BILOBA; INTRACELLULAR FLUID; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; RAT; SALVIA MILTIORRHIZA; ULTRASTRUCTURE;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BENZOFURANS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FLOW CYTOMETRY; GINKGO BILOBA; INTRACELLULAR FLUID; MICROSCOPY, ELECTRON; NEUROPROTECTIVE AGENTS; PC12 CELLS; PEPTIDE FRAGMENTS; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; REACTIVE OXYGEN SPECIES; SALVIA MILTIORRHIZA;

EID: 33750153762     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy [J]. Physiol Rev, 2001,81:741-766.
2. Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red [J]. Proc Natl Acad Sci USA, 1994,91:12243-12247.
3. Pike CJ, Burdick D, Walencewicz AJ, et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state [J]. J Neurosci, 1993,13:1676-1687.
4. Hensley K, Carney JM, Mattson MP, et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease [J]. Proc Natl Acad Sci USA, 1994,91:3270-3274.
5. Goodman Y, Steiner MR, Steiner SM, et al. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation [J]. Brain Res, 1994,654: 171-176.
6. Subramaniam R, Koppal T, Green M, et al. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease [J]. Neurochem Res, 1998,23:1403-1410.
7. Pappolla MA, Sos M, Omar RA, et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide [J]. J Neurosci, 1997,17: 1683-1690.
8. Zeng H, Chen Q, Zhao B. Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis [J]. Free Radic Biol Med, 2004, 36: 180-188.
9. Li J, He LY, Song WZ. Separation and quantitative determination of seven aqueous depsides in Salvia miltiorrhiza by HPTLC scanning [J]. Acta Pharm Sin, 1993,28:543-547.
10. Du GH, Qiu Y, Zhang JT. Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice [J]. J Asian Nat Prod Res, 2000,2:145-152.
11. Chen YH, Du GH, Zhang JT. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats [J]. Acta Pharmacol Sin, 2000,21:463-466.
12. Yao Z, Drieu K, Papadopoulos V. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands [J]. Brain Res, 2001,889:181-190.
13. Luo Y, Smith JV, Paramasivam V, et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb 761 [J]. Proc Natl Acad Sci USA, 2002,99:12197-12202.
14. Pappolla M, Bozner P, Soto C, et al. Inhibition of Alzheimer beta-fibrillogenesis by melatonin [J]. J Biol Chem, 1998,273:7185-7188.
15. Ding Y, He LR, Cao KJ, et al. Apoptosis of human carcinoma of mouth floor KB cells and multidrug resistant KBv200 cells induced by azide methyl anthraquinone derivative [J]. Acta Pharm Sin, 2005,40: 22-26.
16. Zhang ZX, Zahner GE, Roman GC, et al. Studies on the prevalence of subtype of dementia in Beijing, Xi'an, Shanghai and Chengdu [J]. Chin J Contemp Neurol Neurosurg, 2005,5:156-157.
17. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics [J]. Science, 2002,297:353-356.
18. Tomiyama T, Shoji A, Kataoka K, et al. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger [J]. J Biol Chem, 1996,271:6839-6844.
19. Li LN. Water soluble active components of Salvia miltiorrhiza and related plants [J]. J Chin Pharm Sci, 1997,6:57-64.
20. Ono K, Hasegawa K, Naiki H, et al. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro [J]. J Neurosci Res, 2004,75: 742-750.